Occlusion of the Superior Mesenteric Artery in Rats Reversed by Collateral Pathways Activation: Gastric Pentadecapeptide BPC 157 Therapy Counteracts Multiple Organ Dysfunction Syndrome; Intracranial, Portal, and Caval Hypertension; and Aortal Hypotension
Gastric pentadecapeptide BPC 157 therapy counteracts multiple organ dysfunction syndrome in rats, which have permanent occlusion of the superior mesenteric artery close to the abdominal aorta. Previously, when confronted with major vessel occlusion, its effect would rapidly activate collateral vesse...
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2021-05-01
|
| Series: | Biomedicines |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2227-9059/9/6/609 |
| _version_ | 1797532561819303936 |
|---|---|
| author | Mario Knezevic Slaven Gojkovic Ivan Krezic Helena Zizek Dominik Malekinusic Borna Vrdoljak Hrvoje Vranes Tamara Knezevic Ivan Barisic Katarina Horvat Pavlov Domagoj Drmic Miro Staroveski Antonija Djuzel Zoran Rajkovic Toni Kolak Ivica Kocman Eva Lovric Marija Milavic Suncana Sikiric Ante Tvrdeic Leonardo Patrlj Sanja Strbe Antonio Kokot Alenka Boban Blagaic Anita Skrtic Sven Seiwerth Predrag Sikiric |
| author_facet | Mario Knezevic Slaven Gojkovic Ivan Krezic Helena Zizek Dominik Malekinusic Borna Vrdoljak Hrvoje Vranes Tamara Knezevic Ivan Barisic Katarina Horvat Pavlov Domagoj Drmic Miro Staroveski Antonija Djuzel Zoran Rajkovic Toni Kolak Ivica Kocman Eva Lovric Marija Milavic Suncana Sikiric Ante Tvrdeic Leonardo Patrlj Sanja Strbe Antonio Kokot Alenka Boban Blagaic Anita Skrtic Sven Seiwerth Predrag Sikiric |
| author_sort | Mario Knezevic |
| collection | DOAJ |
| description | Gastric pentadecapeptide BPC 157 therapy counteracts multiple organ dysfunction syndrome in rats, which have permanent occlusion of the superior mesenteric artery close to the abdominal aorta. Previously, when confronted with major vessel occlusion, its effect would rapidly activate collateral vessel pathways and resolve major venous occlusion syndromes (Pringle maneuver ischemia, reperfusion, Budd–Chiari syndrome) in rats. This would overwhelm superior mesenteric artery permanent occlusion, and result in local, peripheral, and central disturbances. <b>Methods:</b> Assessments, for 30 min (gross recording, angiography, ECG, pressure, microscopy, biochemistry, and oxidative stress), included the portal hypertension, caval hypertension, and aortal hypotension, and centrally, the superior sagittal sinus hypertension; systemic arterial and venous thrombosis; ECG disturbances; MDA-tissue increase; and multiple organ lesions and disturbances, including the heart, lung, liver, kidney, and gastrointestinal tract, in particular, as well as brain (cortex (cerebral, cerebellar), hypothalamus/thalamus, hippocampus). BPC 157 therapy (/kg, abdominal bath) (10 µg, 10 ng) was given for a 1-min ligation time. <b>Results:</b> BPC 157 rapidly recruits collateral vessels (inferior anterior pancreaticoduodenal artery and inferior mesenteric artery) that circumvent occlusion and ascertains blood flow distant from the occlusion in the superior mesenteric artery. Portal and caval hypertension, aortal hypotension, and, centrally, superior sagittal sinus hypertension were attenuated or eliminated, and ECG disturbances markedly mitigated. BPC 157 therapy almost annihilated venous and arterial thrombosis. Multiple organ lesions and disturbances (i.e., heart, lung, liver, and gastrointestinal tract, in particular, as well as brain) were largely attenuated. <b>Conclusions</b>: Rats with superior mesenteric artery occlusion may additionally undergo BPC 157 therapy as full counteraction of vascular occlusion-induced multiple organ dysfunction syndrome. |
| first_indexed | 2024-03-10T11:01:00Z |
| format | Article |
| id | doaj.art-ef8b3da4547e4dd38b9cd3dd1b982bed |
| institution | Directory Open Access Journal |
| issn | 2227-9059 |
| language | English |
| last_indexed | 2024-03-10T11:01:00Z |
| publishDate | 2021-05-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Biomedicines |
| spelling | doaj.art-ef8b3da4547e4dd38b9cd3dd1b982bed2023-11-21T21:32:14ZengMDPI AGBiomedicines2227-90592021-05-019660910.3390/biomedicines9060609Occlusion of the Superior Mesenteric Artery in Rats Reversed by Collateral Pathways Activation: Gastric Pentadecapeptide BPC 157 Therapy Counteracts Multiple Organ Dysfunction Syndrome; Intracranial, Portal, and Caval Hypertension; and Aortal HypotensionMario Knezevic0Slaven Gojkovic1Ivan Krezic2Helena Zizek3Dominik Malekinusic4Borna Vrdoljak5Hrvoje Vranes6Tamara Knezevic7Ivan Barisic8Katarina Horvat Pavlov9Domagoj Drmic10Miro Staroveski11Antonija Djuzel12Zoran Rajkovic13Toni Kolak14Ivica Kocman15Eva Lovric16Marija Milavic17Suncana Sikiric18Ante Tvrdeic19Leonardo Patrlj20Sanja Strbe21Antonio Kokot22Alenka Boban Blagaic23Anita Skrtic24Sven Seiwerth25Predrag Sikiric26Department of Pharmacology, School of Medicine, University of Zagreb, 10000 Zagreb, CroatiaDepartment of Pharmacology, School of Medicine, University of Zagreb, 10000 Zagreb, CroatiaDepartment of Pharmacology, School of Medicine, University of Zagreb, 10000 Zagreb, CroatiaDepartment of Pharmacology, School of Medicine, University of Zagreb, 10000 Zagreb, CroatiaDepartment of Pharmacology, School of Medicine, University of Zagreb, 10000 Zagreb, CroatiaDepartment of Pharmacology, School of Medicine, University of Zagreb, 10000 Zagreb, CroatiaDepartment of Pharmacology, School of Medicine, University of Zagreb, 10000 Zagreb, CroatiaDepartment of Pharmacology, School of Medicine, University of Zagreb, 10000 Zagreb, CroatiaDepartment of Pharmacology, School of Medicine, University of Zagreb, 10000 Zagreb, CroatiaDepartment of Pathology, School of Medicine, University of Zagreb, 10000 Zagreb, CroatiaDepartment of Pharmacology, School of Medicine, University of Zagreb, 10000 Zagreb, CroatiaDepartment of Pharmacology, School of Medicine, University of Zagreb, 10000 Zagreb, CroatiaDepartment of Pharmacology, School of Medicine, University of Zagreb, 10000 Zagreb, CroatiaDepartment of Surgery, Faculty of Dental Medicine and Health, University of Osijek, 31000 Osijek, CroatiaDepartment of Pharmacology, School of Medicine, University of Zagreb, 10000 Zagreb, CroatiaDepartment of Pharmacology, School of Medicine, University of Zagreb, 10000 Zagreb, CroatiaDepartment of Pathology, School of Medicine, University of Zagreb, 10000 Zagreb, CroatiaDepartment of Pathology, School of Medicine, University of Zagreb, 10000 Zagreb, CroatiaDepartment of Pathology, School of Medicine, University of Zagreb, 10000 Zagreb, CroatiaDepartment of Pharmacology, School of Medicine, University of Zagreb, 10000 Zagreb, CroatiaDepartment of Pharmacology, School of Medicine, University of Zagreb, 10000 Zagreb, CroatiaDepartment of Pharmacology, School of Medicine, University of Zagreb, 10000 Zagreb, CroatiaDepartment of Anatomy and Neuroscience, School of Medicine, Josip Juraj Strossmayer University of Osijek, 31000 Osijek, CroatiaDepartment of Pharmacology, School of Medicine, University of Zagreb, 10000 Zagreb, CroatiaDepartment of Pathology, School of Medicine, University of Zagreb, 10000 Zagreb, CroatiaDepartment of Pathology, School of Medicine, University of Zagreb, 10000 Zagreb, CroatiaDepartment of Pharmacology, School of Medicine, University of Zagreb, 10000 Zagreb, CroatiaGastric pentadecapeptide BPC 157 therapy counteracts multiple organ dysfunction syndrome in rats, which have permanent occlusion of the superior mesenteric artery close to the abdominal aorta. Previously, when confronted with major vessel occlusion, its effect would rapidly activate collateral vessel pathways and resolve major venous occlusion syndromes (Pringle maneuver ischemia, reperfusion, Budd–Chiari syndrome) in rats. This would overwhelm superior mesenteric artery permanent occlusion, and result in local, peripheral, and central disturbances. <b>Methods:</b> Assessments, for 30 min (gross recording, angiography, ECG, pressure, microscopy, biochemistry, and oxidative stress), included the portal hypertension, caval hypertension, and aortal hypotension, and centrally, the superior sagittal sinus hypertension; systemic arterial and venous thrombosis; ECG disturbances; MDA-tissue increase; and multiple organ lesions and disturbances, including the heart, lung, liver, kidney, and gastrointestinal tract, in particular, as well as brain (cortex (cerebral, cerebellar), hypothalamus/thalamus, hippocampus). BPC 157 therapy (/kg, abdominal bath) (10 µg, 10 ng) was given for a 1-min ligation time. <b>Results:</b> BPC 157 rapidly recruits collateral vessels (inferior anterior pancreaticoduodenal artery and inferior mesenteric artery) that circumvent occlusion and ascertains blood flow distant from the occlusion in the superior mesenteric artery. Portal and caval hypertension, aortal hypotension, and, centrally, superior sagittal sinus hypertension were attenuated or eliminated, and ECG disturbances markedly mitigated. BPC 157 therapy almost annihilated venous and arterial thrombosis. Multiple organ lesions and disturbances (i.e., heart, lung, liver, and gastrointestinal tract, in particular, as well as brain) were largely attenuated. <b>Conclusions</b>: Rats with superior mesenteric artery occlusion may additionally undergo BPC 157 therapy as full counteraction of vascular occlusion-induced multiple organ dysfunction syndrome.https://www.mdpi.com/2227-9059/9/6/609BPC 157superior mesenteric artery occlusionvascular recruitmentrats |
| spellingShingle | Mario Knezevic Slaven Gojkovic Ivan Krezic Helena Zizek Dominik Malekinusic Borna Vrdoljak Hrvoje Vranes Tamara Knezevic Ivan Barisic Katarina Horvat Pavlov Domagoj Drmic Miro Staroveski Antonija Djuzel Zoran Rajkovic Toni Kolak Ivica Kocman Eva Lovric Marija Milavic Suncana Sikiric Ante Tvrdeic Leonardo Patrlj Sanja Strbe Antonio Kokot Alenka Boban Blagaic Anita Skrtic Sven Seiwerth Predrag Sikiric Occlusion of the Superior Mesenteric Artery in Rats Reversed by Collateral Pathways Activation: Gastric Pentadecapeptide BPC 157 Therapy Counteracts Multiple Organ Dysfunction Syndrome; Intracranial, Portal, and Caval Hypertension; and Aortal Hypotension Biomedicines BPC 157 superior mesenteric artery occlusion vascular recruitment rats |
| title | Occlusion of the Superior Mesenteric Artery in Rats Reversed by Collateral Pathways Activation: Gastric Pentadecapeptide BPC 157 Therapy Counteracts Multiple Organ Dysfunction Syndrome; Intracranial, Portal, and Caval Hypertension; and Aortal Hypotension |
| title_full | Occlusion of the Superior Mesenteric Artery in Rats Reversed by Collateral Pathways Activation: Gastric Pentadecapeptide BPC 157 Therapy Counteracts Multiple Organ Dysfunction Syndrome; Intracranial, Portal, and Caval Hypertension; and Aortal Hypotension |
| title_fullStr | Occlusion of the Superior Mesenteric Artery in Rats Reversed by Collateral Pathways Activation: Gastric Pentadecapeptide BPC 157 Therapy Counteracts Multiple Organ Dysfunction Syndrome; Intracranial, Portal, and Caval Hypertension; and Aortal Hypotension |
| title_full_unstemmed | Occlusion of the Superior Mesenteric Artery in Rats Reversed by Collateral Pathways Activation: Gastric Pentadecapeptide BPC 157 Therapy Counteracts Multiple Organ Dysfunction Syndrome; Intracranial, Portal, and Caval Hypertension; and Aortal Hypotension |
| title_short | Occlusion of the Superior Mesenteric Artery in Rats Reversed by Collateral Pathways Activation: Gastric Pentadecapeptide BPC 157 Therapy Counteracts Multiple Organ Dysfunction Syndrome; Intracranial, Portal, and Caval Hypertension; and Aortal Hypotension |
| title_sort | occlusion of the superior mesenteric artery in rats reversed by collateral pathways activation gastric pentadecapeptide bpc 157 therapy counteracts multiple organ dysfunction syndrome intracranial portal and caval hypertension and aortal hypotension |
| topic | BPC 157 superior mesenteric artery occlusion vascular recruitment rats |
| url | https://www.mdpi.com/2227-9059/9/6/609 |
| work_keys_str_mv | AT marioknezevic occlusionofthesuperiormesentericarteryinratsreversedbycollateralpathwaysactivationgastricpentadecapeptidebpc157therapycounteractsmultipleorgandysfunctionsyndromeintracranialportalandcavalhypertensionandaortalhypotension AT slavengojkovic occlusionofthesuperiormesentericarteryinratsreversedbycollateralpathwaysactivationgastricpentadecapeptidebpc157therapycounteractsmultipleorgandysfunctionsyndromeintracranialportalandcavalhypertensionandaortalhypotension AT ivankrezic occlusionofthesuperiormesentericarteryinratsreversedbycollateralpathwaysactivationgastricpentadecapeptidebpc157therapycounteractsmultipleorgandysfunctionsyndromeintracranialportalandcavalhypertensionandaortalhypotension AT helenazizek occlusionofthesuperiormesentericarteryinratsreversedbycollateralpathwaysactivationgastricpentadecapeptidebpc157therapycounteractsmultipleorgandysfunctionsyndromeintracranialportalandcavalhypertensionandaortalhypotension AT dominikmalekinusic occlusionofthesuperiormesentericarteryinratsreversedbycollateralpathwaysactivationgastricpentadecapeptidebpc157therapycounteractsmultipleorgandysfunctionsyndromeintracranialportalandcavalhypertensionandaortalhypotension AT bornavrdoljak occlusionofthesuperiormesentericarteryinratsreversedbycollateralpathwaysactivationgastricpentadecapeptidebpc157therapycounteractsmultipleorgandysfunctionsyndromeintracranialportalandcavalhypertensionandaortalhypotension AT hrvojevranes occlusionofthesuperiormesentericarteryinratsreversedbycollateralpathwaysactivationgastricpentadecapeptidebpc157therapycounteractsmultipleorgandysfunctionsyndromeintracranialportalandcavalhypertensionandaortalhypotension AT tamaraknezevic occlusionofthesuperiormesentericarteryinratsreversedbycollateralpathwaysactivationgastricpentadecapeptidebpc157therapycounteractsmultipleorgandysfunctionsyndromeintracranialportalandcavalhypertensionandaortalhypotension AT ivanbarisic occlusionofthesuperiormesentericarteryinratsreversedbycollateralpathwaysactivationgastricpentadecapeptidebpc157therapycounteractsmultipleorgandysfunctionsyndromeintracranialportalandcavalhypertensionandaortalhypotension AT katarinahorvatpavlov occlusionofthesuperiormesentericarteryinratsreversedbycollateralpathwaysactivationgastricpentadecapeptidebpc157therapycounteractsmultipleorgandysfunctionsyndromeintracranialportalandcavalhypertensionandaortalhypotension AT domagojdrmic occlusionofthesuperiormesentericarteryinratsreversedbycollateralpathwaysactivationgastricpentadecapeptidebpc157therapycounteractsmultipleorgandysfunctionsyndromeintracranialportalandcavalhypertensionandaortalhypotension AT mirostaroveski occlusionofthesuperiormesentericarteryinratsreversedbycollateralpathwaysactivationgastricpentadecapeptidebpc157therapycounteractsmultipleorgandysfunctionsyndromeintracranialportalandcavalhypertensionandaortalhypotension AT antonijadjuzel occlusionofthesuperiormesentericarteryinratsreversedbycollateralpathwaysactivationgastricpentadecapeptidebpc157therapycounteractsmultipleorgandysfunctionsyndromeintracranialportalandcavalhypertensionandaortalhypotension AT zoranrajkovic occlusionofthesuperiormesentericarteryinratsreversedbycollateralpathwaysactivationgastricpentadecapeptidebpc157therapycounteractsmultipleorgandysfunctionsyndromeintracranialportalandcavalhypertensionandaortalhypotension AT tonikolak occlusionofthesuperiormesentericarteryinratsreversedbycollateralpathwaysactivationgastricpentadecapeptidebpc157therapycounteractsmultipleorgandysfunctionsyndromeintracranialportalandcavalhypertensionandaortalhypotension AT ivicakocman occlusionofthesuperiormesentericarteryinratsreversedbycollateralpathwaysactivationgastricpentadecapeptidebpc157therapycounteractsmultipleorgandysfunctionsyndromeintracranialportalandcavalhypertensionandaortalhypotension AT evalovric occlusionofthesuperiormesentericarteryinratsreversedbycollateralpathwaysactivationgastricpentadecapeptidebpc157therapycounteractsmultipleorgandysfunctionsyndromeintracranialportalandcavalhypertensionandaortalhypotension AT marijamilavic occlusionofthesuperiormesentericarteryinratsreversedbycollateralpathwaysactivationgastricpentadecapeptidebpc157therapycounteractsmultipleorgandysfunctionsyndromeintracranialportalandcavalhypertensionandaortalhypotension AT suncanasikiric occlusionofthesuperiormesentericarteryinratsreversedbycollateralpathwaysactivationgastricpentadecapeptidebpc157therapycounteractsmultipleorgandysfunctionsyndromeintracranialportalandcavalhypertensionandaortalhypotension AT antetvrdeic occlusionofthesuperiormesentericarteryinratsreversedbycollateralpathwaysactivationgastricpentadecapeptidebpc157therapycounteractsmultipleorgandysfunctionsyndromeintracranialportalandcavalhypertensionandaortalhypotension AT leonardopatrlj occlusionofthesuperiormesentericarteryinratsreversedbycollateralpathwaysactivationgastricpentadecapeptidebpc157therapycounteractsmultipleorgandysfunctionsyndromeintracranialportalandcavalhypertensionandaortalhypotension AT sanjastrbe occlusionofthesuperiormesentericarteryinratsreversedbycollateralpathwaysactivationgastricpentadecapeptidebpc157therapycounteractsmultipleorgandysfunctionsyndromeintracranialportalandcavalhypertensionandaortalhypotension AT antoniokokot occlusionofthesuperiormesentericarteryinratsreversedbycollateralpathwaysactivationgastricpentadecapeptidebpc157therapycounteractsmultipleorgandysfunctionsyndromeintracranialportalandcavalhypertensionandaortalhypotension AT alenkabobanblagaic occlusionofthesuperiormesentericarteryinratsreversedbycollateralpathwaysactivationgastricpentadecapeptidebpc157therapycounteractsmultipleorgandysfunctionsyndromeintracranialportalandcavalhypertensionandaortalhypotension AT anitaskrtic occlusionofthesuperiormesentericarteryinratsreversedbycollateralpathwaysactivationgastricpentadecapeptidebpc157therapycounteractsmultipleorgandysfunctionsyndromeintracranialportalandcavalhypertensionandaortalhypotension AT svenseiwerth occlusionofthesuperiormesentericarteryinratsreversedbycollateralpathwaysactivationgastricpentadecapeptidebpc157therapycounteractsmultipleorgandysfunctionsyndromeintracranialportalandcavalhypertensionandaortalhypotension AT predragsikiric occlusionofthesuperiormesentericarteryinratsreversedbycollateralpathwaysactivationgastricpentadecapeptidebpc157therapycounteractsmultipleorgandysfunctionsyndromeintracranialportalandcavalhypertensionandaortalhypotension |